Luxury shoemaker Bally, which was founded in Switzerland in 1851, has again changed hands. China’s Shandong Ruyi has agreed to buy a controlling stake in the firm from Luxembourg-based JAB Holding, the companies said on Friday.
“This is an important milestone for Shandong Ruyi Group in our enterprise to become a global leader in the fashion apparel sector,” Yafu Qiu, Chairman of Shandong Ruyi GroupExternal link, said in a statement. “We look forward to supporting Bally in achieving its continued growth and enhancing its brand globally.”
Shandong Ruyi has been slowly building its network of luxury clothing and accessories labels
Bally External linkwas founded by Carl Franz Bally at Schönenwerd in canton Solothurn in 1851. The brand was sold to Werner K. Rey in 1976. A year later it was bought by the Zurich group Oerlikon-Bührle. It was later bought by the US investor Texas Pacific Group in 1999, before being taken over by JAB Holding in 2008 and is now headquartered in Milan.
Bally’s parent company, JAB Holdings has been selling off its luxury and fashion investments. It will retain an undisclosed minority stake in Bally.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
No Swiss protection for Louboutin’s red-soled shoes
This content was published on
On Friday, the Federal Supreme Court in Lausanne turned down Louboutin’s demand for protection stating that the red soles are merely an aesthetic element and are thus not deserving of trademark protection. The court added that just because the brand managed to wrangle trademark status for its red soles in other countries like China, Russia…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.